LuciDap

Description

COMPOSITION:

Each film-coated tablet contains Daprodustat ……………………………….. 1mg.

INDICATION:

LuciDap is a hypoxia-inducible factor prolyl hydroxylase (HIF PH)inhibitor indicated for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months.

DOSAGE AND USE:

• Administer orally once daily, with or without food.

• The recommended dosage of LuciDap is

2 mg or 4 mg once.Afterwards, the dosage can be adjusted according to the patient’s condition.

• 24 mg is the maximum recommended once daily dose.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciDap during Pregnancy and Lactation.